Skip to main content
. 2020 Nov 20;2(1):100014. doi: 10.1016/j.xhgg.2020.100014

Table 1.

Variant information and phenotypes of individuals with ultra-rare POLR2A variants

Individual ID 1 2 3 4 5 6 7 (Haijes et al.6individual 15) 8 9 10 11 12 Summary
Consented to sharing of individual-level phenotypes? yes yes yes yes yes yes yes yes no no no no NA
Sex F M M M F F F F M F M M NA
Age (in years, at requisition or most recent phenotyping) 0.32 4 3.5 10 21 6.75 11 14 1.13 16.12 1.49 4.36 NA

Molecular

Previous/additional Molecular Diagnosis unsolved unsolved unsolved unsolved unsolved unsolved mitochondrial complex IV deficiency indicated via skeletal muscle enzyme analysis; mtDNA sequencing was negative unsolved unsolved unsolved unsolved unsolved NA
Chromosome 17 17 17 17 17 17 17 17 17 17 17 17 NA
Position 7401503 7411610 7411736 7412890 7412890 7415280 7416391 7417020 7388166 7399625 7399813 7411604 NA
Genomic variant GACCTTC>G C>T C>T A>G A>G G>A G>A CCA>C C>G G>A C>T C>T NA
cDNA variant c.1314_1319del c.3281C>T c.3407C>T c.3752A>G c.3752A>G c.4252G>A c.4808G>A c.5440_5441del c.83C>G c.323G>A c.418C>T c.3275C>T NA
Amino acid change p.Leu438_His439del p.Ser1094Phe p.Thr1136Ile p.Asn1251Ser p.Asn1251Ser p.Gly1418Arg p.Arg1603His p.Gln1814Valfs99ter p.Pro28Arg p.Arg108His p.Arg140Trp p.Ala1092Val NA
GERP++ score (conservation) mean = 4.64 (0.89–5.6; SD = 1.9; 6 bases) 5.36 5.23 5.11 5.11 5.06 3.93 mean = 1.68 (−8.25–4.13; SD = 3.06; 476 bases) 5.82 5.57 5.57 5.36 NA
MTR score (31 bp) (missense constraint) mean = 0.675 (0.637–0.678; 2 amino acids) 0.477 0.172 0.516 0.516 0.301 1.031 mean = 0.7 (0.448–0.968; SD = 0.131; 158 amino acids) 0.598 0.649 0.673 0.528 NA
Zygosity het het het het het het het het het het het het NA
De novo in proband? yes yes yes yes yes yes yes no; inherited from mother with mild difficulty learning ? ? ? ? NA
Yeast variant phenotype transcription defect (weak) (yeast Ile424Δ corresponds to human p.Leu438del) ? ? ? ? transcription defect (slight) ? ? protein defect (strong) protein defect (weak) protein defect (strong) transcription defect (weak) NA

Phenotypes

Short stature (HP:0004322) + 5th percentile 3/4 5/12

Head and neck

Dysmorphic features (HP:0001999) + high anterior hairline; mild downslanting palpebral fissures; strabismus high anterior hairline; epicanthus; downslanting palpebral fissures; long lateral palpebral fissures; tented upper lip vermilion; prominent ears prominent supraorbital ridges; high posterior hairline; upslanted palpebral fissures; fair complexion; deeply set eyes; large ear lobes; high palate broad forehead; bilateral epicanthus; prominent supraorbital ridges; fair complexion; deeply set eyes; strabismus (when tired) prominent ears; thin upper lip vermilion; smooth philtrum NP 3/4 9/12
Abnormal brain MRI (HP:0012443) polymicrogyria (HP:0002126), ventriculomegaly (HP:0002119), hydrocephalus (HP:0000238), hypomyelination (HP:0006808) Rathke cleft cyst thin corpus collosum (HP:0002079), mild pontine and interior vermian hypoplasia (HP:0012110, HP:0007068), enlargement of the fourth ventricle (HP:0002198), delayed myelination (HP:0012448) prominent third and lateral ventricles at 1 year old (HP:0007082, HP:0006956) thin corpus collosum (HP:0002079), ventriculomegaly (HP:0002119), 7 mm cyst in temporal parietal junction, bilateral loss of white matter (HP:0012429) polymicrogyria involving large portions of left cerebral hemisphere including perisylvian region and portions of the left frontal, parietal, and temporal lobes (HP:0002126); left cerebral atrophy (HP:0002059); small enhancing developmental venous anomaly at right parieto-occipital junction (HP:0012481) 1/4 7/12
Microcephaly/ macrocephaly NP significant microcephaly (<2 percentile) microcephaly macrocephaly 1/4 3/12
Visual impairment (HP:0000505) NP astigmatism, both eyes bilateral elongation of ocular globes noted on MRI cortical irregular astigmatism, both eyes wears glasses since age 2 years, no astigmatism reported NP 5/12
Hearing impairment (HP:0000365) NP sensorineural right-side hearing deficit attributed to hemiplegia NP 2/12
Headache (HP:0002315) NP reported by parents; cannot confirm as individual is non-verbal reported by parents; cannot confirm as individual is non-verbal daily severe headaches NP 1/10

Central nervous system

Developmental delay (HP:0012758) + + + + speech and motor (HP:0000750, HP:0001270) + + speech and motor (HP:0000750, HP:0001270) 4/4 12/12
Developmental regression (HP:0002376) NP three separate 6-month episodes of regression and plateau possible recent regression regression at age 16 years attributed to worsening anxiety, with new aggressive behaviors no regression, but developed personality changes (HP:0000751) and memory problems (HP:0002354) at age 8 years NP 4/12
Seizures (HP:0001250) NP EEG revealed right centroparietal epileptiform discharges generalized tonic-clonic and absence during childhood, with no discernable seizures since puberty, no longer on anticonvulsants absence seizures + started at 13 years old 2/4 8/12
Intellectual disability (HP:0001249) NP + + + + + + mild 1/4 8/12
Autism spectrum disorder (HP:0000729) NP + + + + + 1/4 6/12
Hypotonia (HP:0001252) + + + + + + + 1/4 8/12
Dystonia (HP:0001332) NP + + hypertonia/spasticity of the right extremities due to hemiplegia (HP:0001276, HP:0004374) NP 3/12
Neck and back arching in infancy NP + + + NP NP 3/12
Abnormal movements (HP:0100022) NP hand flapping hand flapping, kicking, rubs side of head head banging occasional hand flapping hand flapping head hitting, stimming arms and legs 1/4 7/12
Pica (HP:0011856) NP eats hair, paper, feces NP frequently puts objects in mouth NP NP chews on hands, toes, clothes, paper, furniture, toys NP NP 3/12
Ataxia (HP:0001251) NP + + + ataxic high-stepping gait + + ataxic gait NP 7/12
Difficulty sleeping (HP:0002360) NP obstructive sleep apnea prior to removal of tonsils and adenoids; sleeps >12 h and exhibits daytime sleepiness + woke up 10× per night in childhood, current symptoms are occasional and mild NP no sleep study, but reportedly very light sleeper insomnia, takes clonidine for it NP 5/12

Musculoskeletal

Skeletal abnormality (HP:0000924) NP mild pectus excavatum (HP:0000767), hip dysplasia (HP:0001385), sixth lumbar vertebrae (HP:0008416) short Achilles tendons have caused foot distortion and difficulty walking (HP:0001771) NP hip dysplasia (HP:0001385), pes planus (HP:0001763), leg length discrepancy (HP:0100559) contractures on right side (HP:0001371), two Achilles tendon release surgeries (HP:0001771) 1/4 5/12
Scoliosis (HP:0002650) NP neurogenic NP 1/12
Joint hypermobility (HP:0001382) NP + + + hyperextensible elbows and knees + 1/4 6/12

GI system

Failure to thrive (HP:0001508)/ feeding difficulty (HP:0011968) + + poor weight gain but normal linear growth + + 2/4 7/12
Uses gastrostomy tube NP planned but not yet inserted inserted at 9 years old inserted at 5 years old NP 3/12
GI reflux (HP:0002020) NP + + + + 1/4 5/12
Constipation (HP:0002019)/ diarrhea (HP:0002014) NP constipation constipation constipation constipation and diarrhea diarrhea 1/4 5/12

Other

Urogenital system (HP:0000119) NP incontinence incontinence neurogenic bladder; incontinence; swollen left kidney after birth; small scrotum, retractile testes toilet trained at age 6 years, still some incontinence NP incontinence history of several urinary tract infections (HP:0000010) kidney abnormality 1/4 7/12
Skin abnormality (HP:0000951) NP easy scarring, keratosis pilaris easy scarring easy scarring keratosis pilaris, facial flushing unspecified abnormality 1/4 5/12
Immune system (HP:0002715) NP neutropenia (HP:0001875); granulocytopenia (HP:0001913); high lymphocyte percentage (HP:0100827) intermittent leukocytosis (HP:0001974) − (no antibiotics needed for >10 years) NP unspecified abnormality 1/4 3/12
Fever (HP:0001954) NP chronic (HP:0001955) fever of unknown etiology (HP:0001955) fever of unknown etiology in childhood (HP:0001955) chronic fever 1/4 4/12
Cardiac abnormality (HP:0001627) dilated cardiomyopathy (HP:0001644) Bicuspid aortic valve (HP:0001647) Atrial septal defect (HP:0001631), congestive heart failure in infancy (HP:0001635) NP NP 3/12
Lung abnormality (HP:0002086) immature lungs (HP:0006703) recurrent upper respiratory infections (HP:0002788); frequent nebulizer use (budesonide and albuterol) recurrent upper respiratory infections (HP:0002788); uses inhaler and nebulizer poor airway clearance requiring vest therapy, suctioning, and cough assist; recurrent upper respiratory infections (HP:0002788) recurrent upper respiratory infections (HP:0002788); hospitalized four times for pneumonia, once for bronchiolitis NP 5/12
Congenital diaphragmatic hernia (HP:0000776) NP 1/4 1/12
Other NP hypothyroidism (HP:0000821); tooth misalignment (HP:0000692); consistently elevated BUN/creatine ratio (HP:0040081), alkaline phosphatase (HP:0004379), and prolactin (HP:0040086) history of angioedema with levetiracetam use (HP:0100665); hemangioma (HP:0001028); 2-vessel umbilical cord (HP:0001195); adverse reaction to therapeutic botulinum toxin; enlarged liver that resolved after birth (HP:0006564); hyponatremia (HP:0002902) psychosis induced by fluoxetine; agitation with sedatives and general anesthesia NP intolerant of wheat and dairy (not allergic); reduced fetal movement (HP:0001558) NP 4/12

All variants are considered likely pathogenic. Phenotypes are indicated as either positive, negative, or not phenotyped or reported (NP) for each individual. For research-consented individuals, individual-level phenotypic information is presented. For the four other clinical individuals (individuals 9–12), phenotypic information is presented in aggregate. The summary column indicates how many individuals were positive for a given phenotype. All cDNA variants are based on the NM_000937.4 transcript definition. All genomic coordinates are based on the hg19 genome build. Human Phenotype Ontology (HPO) IDs are indicated for phenotypes where appropriate. +, positive; −, negative; BUN, blood urea nitrogen; het, heterozygous; GI, gastrointestinal; NA, not applicable.